Global Nanopore Sequencing Market, By Product (Consumables, Instruments), Nucleotide Sequenced (DNA, RNA), Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing), Type of Nanopore (Solid State, Biological, Hybrid), Application (Human Genomics, Clinical Research, Plant Research, Microbiology, Animal Research), End-User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Nanopore Sequencing Market
The nanopore sequencing market is expected to witness market growth at a rate of 12.65% in the forecast period of 2021 to 2028, and is estimated to reach the value of USD 1320.76 million by 2028. Data Bridge Market Research report on nanopore sequencing market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of nanopore sequencing market.
Nanopore sequencing refers to a unique, and scalable technology that allows real-time and direct analysis of long DNA or RNA fragments. The technology works by monitoring changes to an electrical current as nucleic acids are passed through a protein nanopore. The resulting signal is generally decoded for offering specific DNA or RNA sequence.
The rise in prevalence of genetic disorders across the globe acts as one of the major factors driving the growth of nanopore sequencing market. The increase in demand for long read sequencing technologies for DNA and RNA sequencing, and adoption of nanopore sequencing owning to the benefits such as affordability, simultaneous detection of sequences, high accuracy, and base modifications, among others accelerate the market growth. The rise in use of consumables in wide array of procedures such as DNA sequencing and RNA sequencing, and usage of consumables in formerly unmapped applications such as sequencing of novel viruses further influence the market. Additionally, expansion of pharmaceutical and biotechnology companies, increase in the population, improved healthcare infrastructure and rise in concern for genetic diseases amongst individuals positively affects the nanopore sequencing market. Furthermore, use of advanced genetic treatments extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
- On the other hand, concerns regarding error rates are expected to obstruct the market growth. Lack of trained professionals is projected to challenge the nanopore sequencing market in the forecast period of 2021-2028.
This nanopore sequencing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nanopore sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Nanopore Sequencing Market Scope and Market Size
The nanopore sequencing market is segmented on the basis of product, nucleotide sequenced, type, type of nanopore, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the nanopore sequencing market is segmented into consumables and instruments.
- On the basis of nucleotide sequenced, the nanopore sequencing market is segmented into DNA and RNA.
- On the basis of type, the nanopore sequencing market is segmented into direct current sequencing, synthetic DNA and horizontal tunneling current sequencing, optical reading techniques sequencing, and exonuclease sequencing.
- On the basis of type of nanopore, the nanopore sequencing market is segmented into solid state, biological and hybrid.
- On the basis of application, the nanopore sequencing market is segmented into human genomics, clinical research, plant research, microbiology, and animal research.
- On the basis of end-user, the nanopore sequencing market is segmented into biotechnology companies, clinical laboratories, and academic & research institutes.
Nanopore Sequencing Market Country Level Analysis
The nanopore sequencing market is analyzed and market size insights and trends are provided by country, product, nucleotide sequenced, type, type of nanopore, application and end-user as referenced above.
The countries covered in the nanopore sequencing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the nanopore sequencing market because of the quick adoption of advanced technologies within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the large patient population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The nanopore sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nanopore sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanopore sequencing market. The data is available for historic period 2010-2019.
Competitive Landscape and Nanopore Sequencing Market Share Analysis
The nanopore sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to nanopore sequencing market.
The major players covered in the nanopore sequencing market report are QIAGEN, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., BGI, Danaher., GENERAL ELECTRIC COMPANY, Eppendorf AG, Abbott, LI-COR, Inc., Siemens, PerkinElmer Inc., Macrogen Inc., DNASTAR, Geneious, Myriad Genetics, Inc., and Thermo Fisher Scientific, Illumina, Inc., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-